Fibronectin in tissue regeneration: Timely disassembly of the scaffold is necessary to complete the build

Cellular and Molecular Life Sciences

Volumn 70, Issue 22, 2013, Pages 4243-4253

  Stoffels, Josephine M J ^a   Zhao, Chao ^b   Baron, Wia ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Fibronectin; Multiple sclerosis; Osteoarthritis; Tissue regeneration; Wound healing

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CYTOKINE; FIBRONECTIN; HYALURONIC ACID; INTERFERON BETA SERINE; MATRIX METALLOPROTEINASE; MYELIN; NATALIZUMAB; PLATELET DERIVED GROWTH FACTOR; PROTEIN VARIANT; SCAFFOLD PROTEIN; TISSUE SCAFFOLD; TOLL LIKE RECEPTOR 4; VASCULOTROPIN;

ANGIOGENESIS; BIOACCUMULATION; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM DISEASE; CHONDROPATHY; CHRONIC DISEASE; CYTOPLASM; DRUG MECHANISM; EXTRACELLULAR MATRIX; HUMAN; INTERVERTEBRAL DISK DEGENERATION; MULTIPLE SCLEROSIS; NERVE REGENERATION; NONHUMAN; OPSONIZATION; OSTEOARTHRITIS; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN DEFECT; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REGENERATIVE MEDICINE; REMYELINIZATION; REVIEW; SKIN INJURY; TISSUE INJURY; TISSUE REGENERATION; TREATMENT FAILURE; TREATMENT RESPONSE; WHITE MATTER INJURY; WOUND HEALING; CHEMISTRY; METABOLISM; MYELIN SHEATH; PATHOLOGY; PHYSIOLOGY; REGENERATION; TISSUE SCAFFOLD;

EXTRACELLULAR MATRIX; FIBRONECTINS; HUMANS; MULTIPLE SCLEROSIS; MYELIN SHEATH; OSTEOARTHRITIS; REGENERATION; TISSUE SCAFFOLDS; WOUND HEALING;

EID: 84887083278     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-013-1350-0     Document Type: Review

References (149)

1. Nishinarita S, Yamamoto M, Takizawa T, Hayakawa J, Karasaki M, Sawada S (1990) Increased plasma fibronectin in patients with systemic lupus erythematosus. Clin Rheumatol 9:214-219
2. Goos M, Lange P, Hanisch UK, Prinz M, Scheffel J, Bergmann R, Ebert S, Nau R (2007) Fibronectin is elevated in the cerebrospinal fluid of patients suffering from bacterial meningitis and enhances inflammation caused by bacterial products in primary mouse microglial cell cultures. J Neurochem 102:2049-2060
3. Plow EF, Haas TA, Zhang L, Loftus J, Smith JW (2000) Ligand binding to integrins. J Biol Chem 275:21785-21788
4. Pankov R, Yamada KM (2002) Fibronectin at a glance. J Cell Sci 115:3861-3863
5. Mosher DF (1988) Fibronectin. Academic Press, Inc., San Diego
6. George EL, Georges-Labouesse EN, Patel-King RS, Rayburn H, Hynes RO (1993) Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development 119:1079-1091
7. Scanzello CR, Plaas A, Crow MK (2008) Innate immune system activation in osteoarthritis: is osteoarthritis a chronic wound? Curr Opin Rheumatol 20:565-572
8. Velnar T, Bailey T, Smrkolj V (2009) The wound healing process: an overview of the cellular and molecular mechanisms. J Int Med Res 37:1528-1542
9. Tonnesen MG, Feng X, Clark RA (2000) Angiogenesis in wound healing. J Investig Dermatol Symp Proc 5:40-46
10. Baum CL, Arpey CJ (2005) Normal cutaneous wound healing: clinical correlation with cellular and molecular events. Dermatol Surg 31:674-686 (discussion: 686)
11. Clark RA (1988) Potential roles of fibronectin in cutaneous wound repair. Arch Dermatol 124:201-206
12. Colvin RB (1989) In: Mosher DF (ed) Fibronectin in wound healing. Academic Press, Inc., San Diego, pp 213-254
13. Midwood KS, Mao Y, Hsia HC, Valenick LV, Schwarzbauer JE (2006) Modulation of cell-fibronectin matrix interactions during tissue repair. J Investig Dermatol Symp Proc 11:73-78
14. Sakai T, Johnson KJ, Murozono M, Sakai K, Magnuson MA, Wieloch T, Cronberg T, Isshiki A, Erickson HP, Fassler R (2001) Plasma fibronectin supports neuronal survival and reduces brain injury following transient focal cerebral ischemia but is not essential for skin-wound healing and hemostasis. Nat Med 7:324-330
15. Ni H, Yuen PS, Papalia JM, Trevithick JE, Sakai T, Fassler R, Hynes RO, Wagner DD (2003) Plasma fibronectin promotes thrombus growth and stability in injured arterioles. Proc Natl Acad Sci USA 100:2415-2419
16. Brown LF, Dubin D, Lavigne L, Logan B, Dvorak HF, Van de Water L (1993) Macrophages and fibroblasts express embryonic fibronectins during cutaneous wound healing. Am J Pathol 142:793-801
17. Takamiya M, Kumagai R, Nakayashiki N, Aoki Y (2006) A study on mRNA expressions of fibronectin in dermal and cerebral wound healing for wound age estimation. Leg Med (Tokyo) 8:214-219
18. Miller DR, Mankin HJ, Shoji H, D'Ambrosia RD (1984) Identification of fibronectin in preparations of osteoarthritic human cartilage. Connect Tissue Res 12:267-275
19. Sobel RA, Mitchell ME (1989) Fibronectin in multiple sclerosis lesions. Am J Pathol 135:161-168
20. van Horssen J, Bo L, Vos CM, Virtanen I, de Vries HE (2005) Basement membrane proteins in multiple sclerosis-associated inflammatory cuffs: potential role in influx and transport of leukocytes. J Neuropathol Exp Neurol 64:722-729
21. Satoh JI, Tabunoki H, Yamamura T (2009) Molecular network of the comprehensive multiple sclerosis brain-lesion proteome. Mult Scler 15:531-541
22. Hibbits N, Yoshino J, Le TQ, Armstrong RC (2012) Astrogliosis during acute and chronic cuprizone demyelination and implications for remyelination. ASN Neuro 4(6):393-408. doi: 10.1042/AN20120062
23. Stoffels JM, de Jonge JC, Stancic M, Nomden A, van Strien ME, Ma D, Siskova Z, Maier O, ffrench-Constant C, Franklin RJ, Hoekstra D, Zhao C, Baron W (2013) Fibronectin aggregation in multiple sclerosis lesions impairs remyelination. Brain 136:116-131
24. Chevalier X, Claudepierre P, Groult N, Zardi L, Hornebeck W (1996) Presence of ED-A containing fibronectin in human articular cartilage from patients with osteoarthritis and rheumatoid arthritis. J Rheumatol 23:1022-1030
25. Chevalier X, Groult N, Hornebeck W (1996) Increased expression of the Ed-B-containing fibronectin (an embryonic isoform of fibronectin) in human osteoarthritic cartilage. Br J Rheumatol 35:407-415
26. Clark RA (2001) Fibrin and wound healing. Ann NY Acad Sci 936:355-367
27. Clark RA, An JQ, Greiling D, Khan A, Schwarzbauer JE (2003) Fibroblast migration on fibronectin requires three distinct functional domains. J Invest Dermatol 121:695-705
28. Bielefeld KA, Amini-Nik S, Whetstone H, Poon R, Youn A, Wang J, Alman BA (2011) Fibronectin and beta-catenin act in a regulatory loop in dermal fibroblasts to modulate cutaneous healing. J Biol Chem 286:27687-27697
29. Singh P, Reimer CL, Peters JH, Stepp MA, Hynes RO, Van De Water L (2004) The spatial and temporal expression patterns of integrin alpha9beta1 and one of its ligands, the EIIIA segment of fibronectin, in cutaneous wound healing. J Invest Dermatol 123:1176-1181
30. Serini G, Bochaton-Piallat ML, Ropraz P, Geinoz A, Borsi L, Zardi L, Gabbiani G (1998) The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J Cell Biol 142:873-881
31. Kohan M, Muro AF, White ES, Berkman N (2010) EDA-containing cellular fibronectin induces fibroblast differentiation through binding to alpha4beta7 integrin receptor and MAPK/Erk 1/2-dependent signaling. FASEB J 24:4503-4512
32. Muro AF, Chauhan AK, Gajovic S, Iaconcig A, Porro F, Stanta G, Baralle FE (2003) Regulated splicing of the fibronectin EDA exon is essential for proper skin wound healing and normal lifespan. J Cell Biol 162:149-160
33. Tan MH, Sun Z, Opitz SL, Schmidt TE, Peters JH, George EL (2004) Deletion of the alternatively spliced fibronectin EIIIA domain in mice reduces atherosclerosis. Blood 104:11-18
34. Fukuda T, Yoshida N, Kataoka Y, Manabe R, Mizuno-Horikawa Y, Sato M, Kuriyama K, Yasui N, Sekiguchi K (2002) Mice lacking the EDB segment of fibronectin develop normally but exhibit reduced cell growth and fibronectin matrix assembly in vitro. Cancer Res 62:5603-5610
35. Grinnell F, Ho CH, Wysocki A (1992) Degradation of fibronectin and vitronectin in chronic wound fluid: analysis by cell blotting, immunoblotting, and cell adhesion assays. J Invest Dermatol 98:410-416
36. Moor AN, Vachon DJ, Gould LJ (2009) Proteolytic activity in wound fluids and tissues derived from chronic venous leg ulcers. Wound Repair Regen 17:832-839
37. Falanga V (2004) The chronic wound: impaired healing and solutions in the context of wound bed preparation. Blood Cells Mol Dis 32:88-94
38. Widgerow AD (2013) Chronic wounds - is cellular "reception" at fault? Examining integrins and intracellular signalling. Int Wound J 10:185-192
39. Wachtfogel YT, Abrams W, Kucich U, Weinbaum G, Schapira M, Colman RW (1988) Fibronectin degradation products containing the cytoadhesive tetrapeptide stimulate human neutrophil degranulation. J Clin Invest 81:1310-1316
40. Okamura Y, Watari M, Jerud ES, Young DW, Ishizaka ST, Rose J, Chow JC, Strauss JF 3rd (2001) The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem 276:10229-10233
41. Gondokaryono SP, Ushio H, Niyonsaba F, Hara M, Takenaka H, Jayawardana ST, Ikeda S, Okumura K, Ogawa H (2007) The extra domain A of fibronectin stimulates murine mast cells via Toll-like receptor 4. J Leukoc Biol 82:657-665
42. Loeser RF (2008) Molecular mechanisms of cartilage destruction in osteoarthritis. J Musculoskelet Neuronal Interact 8:303-306
43. Edmonds S (2009) Therapeutic targets for osteoarthritis. Maturitas 63:191-194
44. Bing DH, Almeda S, Isliker H, Lahav J, Hynes RO (1982) Fibronectin binds to the C1q component of complement. Proc Natl Acad Sci USA 79:4198-4201
45. Carsons SE, Schwartzman S, Diamond HS, Berkowitz E (1988) Interaction between fibronectin and C1q in rheumatoid synovial fluid and normal plasma. Clin Exp Immunol 72:37-42
46. Lasarte JJ, Casares N, Gorraiz M, Hervas-Stubbs S, Arribillaga L, Mansilla C, Durantez M, Llopiz D, Sarobe P, Borras-Cuesta F, Prieto J, Leclerc C (2007) The extra domain A from fibronectin targets antigens to TLR4-expressing cells and induces cytotoxic T cell responses in vivo. J Immunol 178:748-756
47. Yasuda T (2006) Cartilage destruction by matrix degradation products. Mod Rheumatol 16:197-205
48. Sofat N (2009) Analysing the role of endogenous matrix molecules in the development of osteoarthritis. Int J Exp Pathol 90:463-479
49. Xie DL, Meyers R, Homandberg GA (1992) Fibronectin fragments in osteoarthritic synovial fluid. J Rheumatol 19:1448-1452
50. Zack MD, Arner EC, Anglin CP, Alston JT, Malfait AM, Tortorella MD (2006) Identification of fibronectin neoepitopes present in human osteoarthritic cartilage. Arthr Rheum 54:2912-2922
51. Gendron C, Kashiwagi M, Lim NH, Enghild JJ, Thogersen IB, Hughes C, Caterson B, Nagase H (2007) Proteolytic activities of human ADAMTS-5: comparative studies with ADAMTS-4. J Biol Chem 282:18294-18306
52. Zack MD, Malfait AM, Skepner AP, Yates MP, Griggs DW, Hall T, Hills RL, Alston JT, Nemirovskiy OV, Radabaugh MR, Leone JW, Arner EC, Tortorella MD (2009) ADAM-8 isolated from human osteoarthritic chondrocytes cleaves fibronectin at Ala (271). Arthr Rheum 60:2704-2713
53. Homandberg GA, Hui F (1994) High concentrations of fibronectin fragments cause short-term catabolic effects in cartilage tissue while lower concentrations cause continuous anabolic effects. Arch Biochem Biophys 311:213-218
54. Homandberg GA, Meyers R, Xie DL (1992) Fibronectin fragments cause chondrolysis of bovine articular cartilage slices in culture. J Biol Chem 267:3597-3604
55. Yasuda T, Poole AR (2002) A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway. Arthr Rheum 46:138-148
56. Homandberg GA, Hui F, Wen C, Purple C, Bewsey K, Koepp H, Huch K, Harris A (1997) Fibronectin-fragment-induced cartilage chondrolysis is associated with release of catabolic cytokines. Biochem J 321(Pt 3):751-757
57. Pulai JI, Chen H, Im HJ, Kumar S, Hanning C, Hegde PS, Loeser RF (2005) NF-kappa B mediates the stimulation of cytokine and chemokine expression by human articular chondrocytes in response to fibronectin fragments. J Immunol 174:5781-5788
58. Long D, Blake S, Song XY, Lark M, Loeser RF (2008) Human articular chondrocytes produce IL-7 and respond to IL-7 with increased production of matrix metalloproteinase-13. Arthr Res Ther 10:R23
59. Werb Z, Tremble PM, Behrendtsen O, Crowley E, Damsky CH (1989) Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression. J Cell Biol 109:877-889
60. Xie DL, Hui F, Meyers R, Homandberg GA (1994) Cartilage chondrolysis by fibronectin fragments is associated with release of several proteinases: stromelysin plays a major role in chondrolysis. Arch Biochem Biophys 311:205-212
61. Yasuda T, Poole AR, Shimizu M, Nakagawa T, Julovi SM, Tamamura H, Fujii N, Nakamura T (2003) Involvement of CD44 in induction of matrix metalloproteinases by a COOH-terminal heparin-binding fragment of fibronectin in human articular cartilage in culture. Arthr Rheum 48:1271-1280
62. Stanton H, Ung L, Fosang AJ (2002) The 45-kDa collagen-binding fragment of fibronectin induces matrix metalloproteinase-13 synthesis by chondrocytes and aggrecan degradation by aggrecanases. Biochem J 364:181-190
63. Yasuda T (2011) Activation of Akt leading to NF-kappaB up-regulation in chondrocytes stimulated with fibronectin fragment. Biomed Res 32:209-215
64. Sofat N, Robertson SD, Wait R (2012) Fibronectin III 13-14 domains induce joint damage via Toll-like receptor 4 activation and synergize with interleukin-1 and tumour necrosis factor. J Innate Immun 4:69-79
65. Forsyth CB, Pulai J, Loeser RF (2002) Fibronectin fragments and blocking antibodies to alpha2beta1 and alpha5beta1 integrins stimulate mitogen-activated protein kinase signaling and increase collagenase 3 (matrix metalloproteinase 13) production by human articular chondrocytes. Arthr Rheum 46:2368-2376
66. Homandberg GA, Costa V, Wen C (2002) Fibronectin fragments active in chondrocytic chondrolysis can be chemically cross-linked to the alpha5 integrin receptor subunit. Osteoarthr Cartil 10:938-949
67. Del Carlo M, Schwartz D, Erickson EA, Loeser RF (2007) Endogenous production of reactive oxygen species is required for stimulation of human articular chondrocyte matrix metalloproteinase production by fibronectin fragments. Free Radic Biol Med 42:1350-1358
68. Huhtala P, Humphries MJ, McCarthy JB, Tremble PM, Werb Z, Damsky CH (1995) Cooperative signaling by alpha 5 beta 1 and alpha 4 beta 1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin. J Cell Biol 129:867-879
69. Peters JH, Loredo GA, Benton HP (2002) Is osteoarthritis a "fibronectin-integrin imbalance disorder"? Osteoarthr Cartil 10:831-835
70. Homandberg GA, Meyers R, Williams JM (1993) Intraarticular injection of fibronectin fragments causes severe depletion of cartilage proteoglycans in vivo. J Rheumatol 20:1378-1382
71. Yasuda T, Kakinuma T, Julovi SM, Yoshida M, Hiramitsu T, Akiyoshi M, Nakamura T (2004) COOH-terminal heparin-binding fibronectin fragment induces nitric oxide production in rheumatoid cartilage through CD44. Rheumatology (Oxford) 43:1116-1120
72. Williams JM, Zhang J, Kang H, Ummadi V, Homandberg GA (2003) The effects of hyaluronic acid on fibronectin fragment mediated cartilage chondrolysis in skeletally mature rabbits. Osteoarthr Cartil 11:44-49
73. Homandberg GA, Hui F, Wen C (1996) Fibronectin fragment mediated cartilage chondrolysis. I. Suppression by anti-oxidants. Biochim Biophys Acta 1317:134-142
74. Homandberg GA, Hui F, Wen C (1996) Fibronectin fragment mediated cartilage chondrolysis. II. Reparative effects of anti-oxidants. Biochim Biophys Acta 1317:143-148
75. Homandberg GA, Guo D, Ray LM, Ding L (2006) Mixtures of glucosamine and chondroitin sulfate reverse fibronectin fragment mediated damage to cartilage more effectively than either agent alone. Osteoarthr Cartil 14:793-806
76. Kang Y, Eger W, Koepp H, Williams JM, Kuettner KE, Homandberg GA (1999) Hyaluronan suppresses fibronectin fragment-mediated damage to human cartilage explant cultures by enhancing proteoglycan synthesis. J Orthop Res 17:858-869
77. Yasuda T (2010) Comparison of hyaluronan effects among normal, osteoarthritis, and rheumatoid arthritis cartilages stimulated with fibronectin fragment. Biomed Res 31:63-69
78. Ascherio A, Munger KL, Lunemann JD (2012) The initiation and prevention of multiple sclerosis. Nat Rev Neurol 8:602-612
79. Wolswijk G (1998) Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J Neurosci 18:601-609
80. Wolswijk G (2002) Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord. Brain 125:338-349
81. Trapp BD, Nave KA (2008) Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci 31:247-269
82. Franklin RJ, ffrench-Constant C (2008) Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci 9:839-855
83. Franklin RJ, ffrench-Constant C, Edgar JM, Smith KJ (2012) Neuroprotection and repair in multiple sclerosis. Nat Rev Neurol 8:624-634
84. Ballabh P, Braun A, Nedergaard M (2004) The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis 16:1-13
85. Man S, Tucky B, Bagheri N, Li X, Kochar R, Ransohoff RM (2009) Alpha4 Integrin/FN-CS1 mediated leukocyte adhesion to brain microvascular endothelial cells under flow conditions. J Neuroimmunol 210:92-99
86. Rudick R, Polman C, Clifford D, Miller D, Steinman L (2013) Natalizumab: bench to bedside and beyond. JAMA Neurol 70:172-182
87. van der Laan LJ, De Groot CJ, Elices MJ, Dijkstra CD (1997) Extracellular matrix proteins expressed by human adult astrocytes in vivo and in vitro: an astrocyte surface protein containing the CS1 domain contributes to binding of lymphoblasts. J Neurosci Res 50:539-548
88. van der Laan LJ, van der Goes A, Wauben MH, Ruuls SR, Dopp EA, De Groot CJ, Kuijpers TW, Elices MJ, Dijkstra CD (2002) Beneficial effect of modified peptide inhibitor of alpha4 integrins on experimental allergic encephalomyelitis in Lewis rats. J Neurosci Res 67:191-199
89. Stuve O, Dooley NP, Uhm JH, Antel JP, Francis GS, Williams G, Yong VW (1996) Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9. Ann Neurol 40:853-863
90. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, MacDonald DD, Jin DK, Shido K, Kerns SA, Zhu Z, Hicklin D, Wu Y, Port JL, Altorki N, Port ER, Ruggero D, Shmelkov SV, Jensen KK, Rafii S, Lyden D (2005) VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438:820-827
91. Malik G, Knowles LM, Dhir R, Xu S, Yang S, Ruoslahti E, Pilch J (2010) Plasma fibronectin promotes lung metastasis by contributions to fibrin clots and tumor cell invasion. Cancer Res 70:4327-4334
92. Reticker-Flynn NE, Malta DF, Winslow MM, Lamar JM, Xu MJ, Underhill GH, Hynes RO, Jacks TE, Bhatia SN (2012) A combinatorial extracellular matrix platform identifies cell-extracellular matrix interactions that correlate with metastasis. Nat Commun 3:1122
93. Milner R, Crocker SJ, Hung S, Wang X, Frausto RF, del Zoppo GJ (2007) Fibronectin- and vitronectin-induced microglial activation and matrix metalloproteinase-9 expression is mediated by integrins alpha5beta1 and alphavbeta5. J Immunol 178:8158-8167
94. Bsibsi M, Ravid R, Gveric D, van Noort JM (2002) Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol 61:1013-1021
95. Lehnardt S, Lachance C, Patrizi S, Lefebvre S, Follett PL, Jensen FE, Rosenberg PA, Volpe JJ, Vartanian T (2002) The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J Neurosci 22:2478-2486
96. Summers L, Kielty C, Pinteaux E (2009) Adhesion to fibronectin regulates interleukin-1 beta expression in microglial cells. Mol Cell Neurosci 41:148-155
97. Ribes S, Ebert S, Regen T, Czesnik D, Scheffel J, Zeug A, Bunkowski S, Eiffert H, Hanisch UK, Hammerschmidt S, Nau R (2010) Fibronectin stimulates Escherichia coli phagocytosis by microglial cells. Glia 58:367-376
98. Kotter MR, Li WW, Zhao C, Franklin RJ (2006) Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J Neurosci 26:328-332
99. Li WW, Setzu A, Zhao C, Franklin RJ (2005) Minocycline-mediated inhibition of microglia activation impairs oligodendrocyte progenitor cell responses and remyelination in a non-immune model of demyelination. J Neuroimmunol 158:58-66
100. Setzu A, Lathia JD, Zhao C, Wells K, Rao MS, ffrench-Constant C, Franklin RJ (2006) Inflammation stimulates myelination by transplanted oligodendrocyte precursor cells. Glia 54:297-303
101. Tate CC, Garcia AJ, LaPlaca MC (2007) Plasma fibronectin is neuroprotective following traumatic brain injury. Exp Neurol 207:13-22
102. Lehnardt S, Massillon L, Follett P, Jensen FE, Ratan R, Rosenberg PA, Volpe JJ, Vartanian T (2003) Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc Natl Acad Sci USA 100:8514-8519
103. Milner R, ffrench-Constant C (1994) A developmental analysis of oligodendroglial integrins in primary cells: changes in alpha v-associated beta subunits during differentiation. Development 120:3497-3506
104. Blaschuk KL, Frost EE, ffrench-Constant C (2000) The regulation of proliferation and differentiation in oligodendrocyte progenitor cells by alphaV integrins. Development 127:1961-1969
105. Zhao C, Fancy SP, Franklin RJ, ffrench-Constant C (2009) Up-regulation of oligodendrocyte precursor cell alphaV integrin and its extracellular ligands during central nervous system remyelination. J Neurosci Res 87:3447-3455
106. Frost E, Kiernan BW, Faissner A, ffrench-Constant C (1996) Regulation of oligodendrocyte precursor migration by extracellular matrix: evidence for substrate-specific inhibition of migration by tenascin-C. Dev Neurosci 18:266-273
107. Milner R, Edwards G, Streuli C, ffrench-Constant C (1996) A role in migration for the alpha V beta 1 integrin expressed on oligodendrocyte precursors. J Neurosci 16:7240-7252
108. Baron W, Shattil SJ, ffrench-Constant C (2002) The oligodendrocyte precursor mitogen PDGF stimulates proliferation by activation of alpha(v)beta3 integrins. EMBO J 21:1957-1966
109. Buttery PC, ffrench-Constant C (1999) Laminin-2/integrin interactions enhance myelin membrane formation by oligodendrocytes. Mol Cell Neurosci 14:199-212
110. Siskova Z, Baron W, de Vries H, Hoekstra D (2006) Fibronectin impedes "myelin" sheet-directed flow in oligodendrocytes: a role for a beta 1 integrin-mediated PKC signaling pathway in vesicular trafficking. Mol Cell Neurosci 33:150-159
111. Siskova Z, Yong VW, Nomden A, van Strien M, Hoekstra D, Baron W (2009) Fibronectin attenuates process outgrowth in oligodendrocytes by mislocalizing MMP-9 activity. Mol Cell Neurosci 42:234-242
112. Zhao C, Fancy SP, Franklin RJ, ffrench-Constant C (2009) Up-regulation of oligodendrocyte precursor cell alphaV integrin and its extracellular ligands during central nervous system remyelination. J Neurosci Res 87:3447-3455
113. Baron W, Decker L, Colognato H, ffrench-Constant C (2003) Regulation of integrin growth factor interactions in oligodendrocytes by lipid raft microdomains. Curr Biol 13:151-155
114. Maier O, van der Heide T, van Dam AM, Baron W, de Vries H, Hoekstra D (2005) Alteration of the extracellular matrix interferes with raft association of neurofascin in oligodendrocytes. Potential significance for multiple sclerosis? Mol Cell Neurosci 28:390-401
115. Singh P, Carraher C, Schwarzbauer JE (2010) Assembly of fibronectin extracellular matrix. Annu Rev Cell Dev Biol 26:397-419
116. To WS, Midwood KS (2011) Plasma and cellular fibronectin: distinct and independent functions during tissue repair. Fibrogenesis Tissue Repair 4:21. doi: 10.1186/1755-1536-4-21
117. Chen H, Mosher DF (1996) Formation of sodium dodecyl sulfate-stable fibronectin multimers. Failure to detect products of thiol-disulfide exchange in cyanogen bromide or limited acid digests of stabilized matrix fibronectin. J Biol Chem 271:9084-9089
118. Ohashi T, Erickson HP (2009) Revisiting the mystery of fibronectin multimers: the fibronectin matrix is composed of fibronectin dimers cross-linked by non-covalent bonds. Matrix Biol 28:170-175
119. McKeown-Longo PJ, Mosher DF (1983) Binding of plasma fibronectin to cell layers of human skin fibroblasts. J Cell Biol 97:466-472
120. Midwood KS, Williams LV, Schwarzbauer JE (2004) Tissue repair and the dynamics of the extracellular matrix. Int J Biochem Cell Biol 36:1031-1037
121. Sottile J, Hocking DC (2002) Fibronectin polymerization regulates the composition and stability of extracellular matrix fibrils and cell-matrix adhesions. Mol Biol Cell 13:3546-3559
122. To WS, Midwood KS (2011) Identification of novel and distinct binding sites within tenascin-C for soluble and fibrillar fibronectin. J Biol Chem 286:14881-14891
123. Ohashi T, Erickson HP (2011) Fibronectin aggregation and assembly: the unfolding of the second fibronectin type III domain. J Biol Chem 286:39188-39199
124. Geiger B, Bershadsky A, Pankov R, Yamada KM (2001) Transmembrane crosstalk between the extracellular matrix-cytoskeleton crosstalk. Nat Rev Mol Cell Biol 2:793-805
125. Nelea V, Nakano Y, Kaartinen MT (2008) Size distribution and molecular associations of plasma fibronectin and fibronectin crosslinked by transglutaminase 2. Protein J 27:223-233
126. van Strien ME, Breve JJ, Fratantoni S, Schreurs MW, Bol JG, Jongenelen CA, Drukarch B, van Dam AM (2011) Astrocyte-derived tissue transglutaminase interacts with fibronectin: a role in astrocyte adhesion and migration? PLoS ONE 6:e25037
127. Dobaczewski M, Gonzalez-Quesada C, Frangogiannis NG (2010) The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction. J Mol Cell Cardiol 48:504-511
128. Arslan F, Smeets MB, Riem Vis PW, Karper JC, Quax PH, Bongartz LG, Peters JH, Hoefer IE, Doevendans PA, Pasterkamp G, de Kleijn DP (2011) Lack of fibronectin-EDA promotes survival and prevents adverse remodeling and heart function deterioration after myocardial infarction. Circ Res 108:582-592
129. Oegema TR Jr, Johnson SL, Aguiar DJ, Ogilvie JW (2000) Fibronectin and its fragments increase with degeneration in the human intervertebral disc. Spine (Phila Pa 1976) 25:2742-2747
130. Greg Anderson D, Li X, Tannoury T, Beck G, Balian G (2003) A fibronectin fragment stimulates intervertebral disc degeneration in vivo. Spine (Phila Pa 1976) 28:2338-2345
131. Xia M, Zhu Y (2011) Fibronectin fragment activation of ERK increasing integrin alpha and beta subunit expression to degenerate nucleus pulposus cells. J Orthop Res 29:556-561
132. Lu P, Takai K, Weaver VM and Werb Z (2011) Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb Perspect Biol 3. doi: 10.1101/cshperspect.a005058
133. Chowdhury TT, Schulz RM, Rai SS, Thuemmler CB, Wuestneck N, Bader A, Homandberg GA (2010) Biomechanical modulation of collagen fragment-induced anabolic and catabolic activities in chondrocyte/agarose constructs. Arthr Res Ther 12:R82
134. Goh FG, Piccinini AM, Krausgruber T, Udalova IA, Midwood KS (2010) Transcriptional regulation of the endogenous danger signal tenascin-C: a novel autocrine loop in inflammation. J Immunol 184:2655-2662
135. Back SA, Tuohy TM, Chen H, Wallingford N, Craig A, Struve J, Luo NL, Banine F, Liu Y, Chang A, Trapp BD, Bebo BF Jr, Rao MS, Sherman LS (2005) Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nat Med 11:966-972
136. Livant DL, Brabec RK, Kurachi K, Allen DL, Wu Y, Haaseth R, Andrews P, Ethier SP, Markwart S (2000) The PHSRN sequence induces extracellular matrix invasion and accelerates wound healing in obese diabetic mice. J Clin Invest 105:1537-1545
137. Miyamoto T, Tamura M, Kabashima N, Serino R, Shibata T, Furuno Y, Miyazaki M, Baba R, Sato N, Doi Y, Okazaki M, Otsuji Y (2010) An integrin-activating peptide, PHSRN, ameliorates inhibitory effects of conventional peritoneal dialysis fluids on peritoneal wound healing. Nephrol Dial Transplant 25:1109-1119
138. Feng Y, Mrksich M (2004) The synergy peptide PHSRN and the adhesion peptide RGD mediate cell adhesion through a common mechanism. Biochemistry 43:15811-15821
139. Zeng ZZ, Yao H, Staszewski ED, Rockwood KF, Markwart SM, Fay KS, Spalding AC, Livant DL (2009) Alpha(5)beta(1) integrin ligand PHSRN induces invasion and alpha(5) mRNA in endothelial cells to stimulate angiogenesis. Transl Oncol 2:8-20
140. Lariviere B, Rouleau M, Picard S, Beaulieu AD (2003) Human plasma fibronectin potentiates the mitogenic activity of platelet-derived growth factor and complements its wound healing effects. Wound Repair Regen 11:79-89
141. Qiu Z, Kwon AH, Kamiyama Y (2007) Effects of plasma fibronectin on the healing of full-thickness skin wounds in streptozotocin-induced diabetic rats. J Surg Res 138:64-70
142. Kwon AH, Qiu Z, Hiraon Y (2007) Effect of plasma fibronectin on the incisional wound healing in rats. Surgery 141:254-261
143. McCulley JP, Horowitz B, Husseini ZM, Horowitz M (1993) Topical fibronectin therapy of persistent corneal epithelial defects. Fibronectin Study Group. Trans Am Ophthalmol Soc 91:367-386 (discussion 386-90)
144. Boateng JS, Matthews KH, Stevens HN, Eccleston GM (2008) Wound healing dressings and drug delivery systems: a review. J Pharm Sci 97:2892-2923
145. Ghosh K, Ren XD, Shu XZ, Prestwich GD, Clark RA (2006) Fibronectin functional domains coupled to hyaluronan stimulate adult human dermal fibroblast responses critical for wound healing. Tissue Eng 12:601-613
146. Okiyama N, Kitajima T, Ito Y, Yokozeki H, Miyasaka N, Kohsaka H (2011) Addition of the collagen binding domain of fibronectin potentiates the biochemical availability of hepatocyte growth factor for cutaneous wound healing. J Dermatol Sci 61:215-217
147. Hamed S, Ullmann Y, Egozi D, Daod E, Hellou E, Ashkar M, Gilhar A, Teot L (2011) Fibronectin potentiates topical erythropoietin-induced wound repair in diabetic mice. J Invest Dermatol 131:1365-1374
148. Martino MM, Tortelli F, Mochizuki M, Traub S, Ben-David D, Kuhn GA, Muller R, Livne E, Eming SA, Hubbell JA (2011) Engineering the growth factor microenvironment with fibronectin domains to promote wound and bone tissue healing. Sci Transl Med 3:100ra89
149. Schwarzbauer JE and DeSimone DW (2011) Fibronectins, their fibrillogenesis, and in vivo functions. Cold Spring Harb Perspect Biol 3. doi: 10.1101/cshperspect.a005041